King's College London

Research portal

Genetic Predisposition to Chronic Lymphocytic Leukemia Is Mediated by a BMF Super-Enhancer Polymorphism

Research output: Contribution to journalArticlepeer-review

Radhika Kandaswamy, Georgina P.Sava, Helen E. Speedy, Sı´lvia Bea, Jose´ I. Martı´n-Subero, James B. Studd, Gabriele Migliorini, Philip J. Law, Xose S Puente, David Martı´n-Garcı´, Itziar Salaverria, Jesu´ s Gutie´rrez-Abril, Carlos Lo´ pez-Otı´n, Daniel Catovsky, James M. Allan, Elı´as Campo, Richard S. Houlston

Original languageEnglish
JournalCell Reports
Early online date11 Aug 2016
Accepted/In press20 Jul 2016
E-pub ahead of print11 Aug 2016


King's Authors


Chronic lymphocytic leukemia (CLL) is an adult B cell malignancy. Genome-wide association studies show that variation at 15q15.1 influences CLL risk. We deciphered the causal variant at 15q15.1 and the mechanism by which it influences tumorigenesis. We imputed all possible genotypes across the locus and then mapped highly associated SNPs to areas of chromatin accessibility, evolutionary conservation, and transcription factor binding. SNP rs539846 C>A, the most highly associated variant (p = 1.42 × 10−13, odds ratio = 1.35), localizes to a super-enhancer defined by extensive histone H3 lysine 27 acetylation in intron 3 of B cell lymphoma 2 (BCL2)-modifying factor (BMF). The rs539846-A risk allele alters a conserved RELA-binding motif, disrupts RELA binding, and is associated with decreased BMF expression in CLL. These findings are consistent with rs539846 influencing CLL susceptibility through differential RELA binding, with direct modulation of BMF expression impacting on anti-apoptotic BCL2, a hallmark of oncogenic dependency in CLL.

Download statistics

No data available

View graph of relations

© 2020 King's College London | Strand | London WC2R 2LS | England | United Kingdom | Tel +44 (0)20 7836 5454